Oaktree Acquisition Corp. III Life Sciences
OACCFinancial ServicesNASDAQShell Companies · Last scanned Oct 26, 2026
Scan Results
Daily timeframeOperating under the Shell Companies umbrella, Oaktree Acquisition Corp. III Life Sciences is a financial services company. III Life Sciences does not have significant operations. The company carries a $263.3M market cap, placing it firmly in the micro-cap category. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
Market Cap
$263.3M
Beta
—
P/E (TTM)
38.25
P/E (Fwd)
—
EPS (TTM)
$0.28
EPS (Fwd)
—
ROE
—
ROA
—
Cash
$1.2M
Total Debt
$11,824
Free CF
—
52W Change
1.0%
Annual Financials
Cash vs Debt
Where OACC stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, OACC finished 0.47% below its 150-day moving average ($10.70) and 0.37% below its 200-day moving average ($10.69). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is OACC overbought or oversold?
At the October 20, 2026 close, OACC's RSI(14) was 39.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $1.2M in cash comfortably exceeding the $12K debt load. A net cash position generally provides financial flexibility during uncertain economic periods.
With cash comfortably exceeding debt, OACC has financial flexibility that may help navigate uncertain periods. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Oaktree Acquisition Corp. III Life Sciences and its sector.